The Safety of Antirheumatic Drugs
CONCLUSION: A suitable, safe antirheumatic drug can be chosen for each patient in consideration of individual risk profiles. Regular monitoring enables the early detection of adverse effects. The risk profile of JAK inhibitors, in particular, will be studied in further trials.PMID:34918622 | DOI:10.3238/arztebl.m2021.0389
Source: Deutsches Arzteblatt International - Category: General Medicine Authors: Johanna Mucke Hans-Uwe Simon Gerd R üdiger Burmester Source Type: research
More News: Cancer & Oncology | Cardiology | Cardiovascular | General Medicine | Heart | Methotrexate | Rheumatology | Thrombosis | Tuberculosis